In this study, significantly high KLF5 expression in the HCC group was associated with TNM stage, tumor size, AFP level, portal vein thrombosis, HBV infection, and the 5-year survival rate of HCC patients (Fig. 1D). Here, KLF5 is linked to hepatocellular carcinoma.